The proposed standard would lower the nicotine content in cigarettes and cigars by 95% – a public health proposal that could prevent millions from becoming smokers in the first place.
Academic rigor, journalistic flair
Articles on Food and Drug Administration
Displaying 1 - 20 of 31 articles
E-cigarettes are facing calls for complete bans on their sale. A tobacco addiction researcher explores the balance between vaping’s harm to teens and potential use as a tool for quitting smoking.
The FDA’s authorization of COVID-19 shots for children ages 6 months to 4 years will bring relief for millions of parents. Pending CDC endorsement, shots for this group will be available within days.
Prescription opiods, stimulants such as those used to treat ADHD and the ingredients found in sexual dysfunction drugs like Viagra are some of the drugs that are being marketed to US consumers.
The closure of a factory in Michigan is the incident that put new parents across the US on edge, but the real causes for the shortage of baby formula are many years in the making.
Products aimed at sexual dysfunction and weight loss were the most common dietary supplements that contained hidden – and potentially harmful – ingredients.
New data on the second booster suggests the older you are, the more you need it.
Drug manufacturers often shun the use of placebos in clinical trials. But research suggests that placebos could play an important role in the treatment of depression, pain and other maladies.
Regulatory loopholes for research conducted off US soil allow for questionable trials and misleading data to slip under the FDA’s radar.
When making the decision whether to vaccinate children aged five to 11 against COVID-19, regulators in Canada must rely on sound ethics as well as sound science.
The FDA has chosen not to regulate lab-developed tests like the ones at the center of the Theranos trial.
COVID-19 has exacerbated a backlog of domestic and foreign drug manufacturing inspections that the FDA is still too short-staffed to adequately deal with.
Australia is still aiming to start vaccinating high-risk groups from March. Why the delay?
The new BinaxNOW antigen test is quick, easy, accurate and cheap. It could solve the US testing problem, but the emergency use authorization only allows people with COVID-19 symptoms to get tested.
Testing large numbers of people regularly would reduce the spread of the coronavirus in the US. Laboratory testing is slow and expensive, but rapid screening tests could be the answer.
After firms add more women to their board, dangerous medical products are recalled more quickly.
The FDA has sped up its approval process for coronavirus treatments, creating a new division to expedite the regulatory process. But is safety being sidelined for speed?
Vaccine development is usually a long process. The coronavirus pandemic is forcing researchers to innovate and test potential vaccines faster than ever before.
Every year, thousands of medical devices and drugs are recalled in the US. But the decision to recall a flawed product is often left up to the manufacturer.
Most Americans underestimate how many calories nutritionists recommend they consume each day, which means maybe you can probably have one more treat without feeling guilty.
Top contributors
-
Professor of Pharmacy Practice, University of Connecticut
-
Associate Professor of Operations and Decision Technologies, Kelley School of Business, Indiana University
-
Associate Professor of Public Policy, University of Maryland, Baltimore County
-
Adjunct Fellow, Computer Science and Software Engineering, Swinburne University of Technology
-
Assistant Professor in Human Genetics, Cold Spring Harbor Laboratory
-
Web Editor, Georgia State University (USA)
-
Assistant Professor of Oncology at the School of Medicine, Johns Hopkins University
-
Adjunct professor, Department of Health Policy & Management, George Washington University
-
Professor and Dean, School of Public Health, Georgia State University
-
Professor, Health Sciences, Simon Fraser University
-
Professor, Department of Geography and Canada Research Chair in Health Service Geographies, Simon Fraser University
-
Professor of Community Health and Health Behavior, University at Buffalo
-
Senior Lecturer in Markets, Public Policy and Law, Questrom School of Business, Boston University
-
Assistant Professor, Northwestern University
-
Honorary Lecturer, School of Pharmacy, Charles Perkins Centre, University of Sydney
